Educational Journal N° 100

boletin_1_es

EDITORIAL
Dr. Matías Sztejfman

ARTICULO DE REVISION
Dr. Fernando Cura
Implante Valvular Aórtico en pacientes de alto riesgo quirúrgico, evidencia y hacia donde nos dirigimos

REVISION BIBLIOGRAFICA
Dr. Yigal Piña Reyna
Estudio CoreValve US Pivotal en Pacientes de alto riesgo quirúrgico

CASO CLINICO
Dres. Gabriel Maluenda, Mario Araya y Michael Howard
TAVI con Sapien XT™ Bajo Sedación Consciente

PASO A PASO
Dr. Dimytri Alexandre Siqueira
Implante Percutáneo de las prótesis CoreValve™ y Sapien XT™

ENTREVISTA CON LOS EXPERTOS
Dr. Mario Araya Hormazábal
Tópicos Polémicos en TAVI

 

 

More articles by this author

See the Presentations of the 13th ProEducar Fellows Course

  During SOLACI-SBHCI 2023, our traditional education program for young interventionists ProEducar Fellows Course was held.  Discover the presentations of the prestigious interventionists that made part of this 13th edition...

The best images of the 13th ProEducar Fellows Course at SOLACI-SBHCI 2023

Relive the best images of the 13th ProEducar Fellows Course held on August 2 during the SOLACI-SBHCI 2023 Congress in the URCA Room of...

ProEducar-SOLACI Fellows Course 2023 – Participate for a grant for the SCAI Fellows Course

For the thirteenth consecutive year, we will be hosting an educational excellence course for interventionalists in training from Latin America: the ProEducar-SOLACI Fellows Course. This one-day...

13th ProEducar Course for Fellow Interventionists at SOLACI-SBHCI 2023

SOLACI-SBHCI 2023 is round the corner and, as every year, we will be allocating a significant part of the event to the 13th ProEducar...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | Asymptomatic Severe Aortic Stenosis: What Should Be our Approach?

Approximately 3% of the population over 65 years old has aortic stenosis. Current guidelines recommend valve replacement for patients with symptoms or an ejection...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...